Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Psychopharmacology (Berl). 2013 Apr 6;229(1):83–94. doi: 10.1007/s00213-013-3088-7

Table 1.

Norepinephrine and Animal Models of Impulsivity-related Behavior

Mechanism Examples Behavioral effect Pharmacology LC effect
NE Reuptake blockade Atomoxetine (Bari and Aston-Jones 2013;Economidou et al. 2012;Paterson et al. 2012), reboxetine (Liu et al. 2009), nortriptyline (Roychowdhury et al. 2012) Improve response- inhibition, working memory, decreased 5CSRT impulsivity but no effect on impulsive choice Reversed by alpha-1, alpha-2, or beta-2 blockade Decrease FR, reduce MHPG, decrease phasic/tonic NE release
Alpha-2 receptor stimulation Guanfacine (Avery et al. 2000), clonidine (Birnbaum et al. 2000) Improve attention and working memory; reverse stress-induced PFC dysfunction Reduced by alpha-1 blockade (medial PFC) or beta-2 blockade (DL PFC) Decrease FR, reduce MHPG, decrease tonic/phasic NE release
Alpha-2 receptor blockade Yohimbine (Arnsten and Dudley 2005;Arnsten and Li 2005;Ma et al. 2005;Mantsch et al. 2010;Sun et al. 2010) Increase stress- induced drug reinstatement and 5CSRT impulsivity; block beneficial effect of MPH Reversed by beta-2 blockade or reduced CREB expression Increase FR and MHPG; increase tonic/phasic release
Alpha-1 receptor stimulation Phenylephrine (Arnsten et al. 1999;Birnbaum et al. 1999) Impaired delayed alternation, working memory and attention Reversed by alpha-1 blockade or lithium
Acute stress Experimental or pharmacological (Arnsten 2000;Mantsch et al. 2010;Otte et al. 2005) Increase drug reinstatement, PFC impairment Reversed by alpha-2 agonist (all effects), beta-2 antagonist (drug reinstatement), alpha-1 antagonist, resembles yohimbine Increase MHPG

Abbreviations: NE Norepinephrine, LC locus coeruleus, MHPG 3,methoxy,4-hydroxyphenylglycol, FR firing rate, PFC prefrontal cortex, DL Dorsolateral, 5CSRT 5-choice serial reaction time test, MPH methylphenidate

HHS Vulnerability Disclosure